Skip to main content
. 2021 May 18;16(5):e0251756. doi: 10.1371/journal.pone.0251756

Table 3. ED patients newly diagnosed with HIV by screening modality and Injection Drug Use (IDU) classification.

Screening Modality* Total (N = 142) IDU (N = 37) No IDU (N = 94) IDU Unknown (N = 11)
Non-targeted opt-out 21 (14.8) 9 (24.3) 9 (9.6) 3 (27.3)
Risk-targeted 52 (36.6) 11 (29.7) 39 (41.5) 2 (18.2)
Walk-in clients 3 (2.1) 0 (0.0) 3 (3.2) 0 (0.0)
Diagnostic tests 66 (46.5) 17 (45.9) 43 (45.7) 6 (54.5)

* All columns are reported as numbers with proportions.